Jim Adox

Jim, a TRS co-founder, is a Managing Director at Venture Investors, LLC ("VI"), a Midwest venture capital firm specializing in seed and early stage healthcare and technology investments. He joined VI in 2007 and heads up their Ann Arbor, Michigan office. Jim's prior venture capital experience includes a combined nine years as a partner at RidgeLine Ventures and EDF Ventures, where he led the spin-out, sourcing, financing, syndication and exit of numerous investments. During this time, he served as President, CFO, and COO of select companies until a management team was recruited. Jim previously served on the Boards of Directors of Avail Networks (acquired by ERI) and HandyLab (acquired by BD), and as an observer for Alfalight, Ardesta, TherOx and Xtera Communications. He currently serves on the Boards of Directors of HistoSonics, Incept BioSystems, and the Michigan Venture Capital Association. Prior to his venture capital positions, Jim had nine years of corporate operating experience in marketing, engineering, business development and operations. Outside of his VI responsibilities, Jim is on the Board of Advisors to the Frankel Commercialization Fund, The Medical Innovations Center, Tech Arb, and Huron River Ventures. Jim earned a B.S. in Mechanical Engineering, an M.S. in Mechanical Engineering and a MBA with High Distinction, all from the University of Michigan.